Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

276
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
276
Cancer Survival Analysis01:21

Cancer Survival Analysis

442
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
442
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

246
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
246

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Domo Arigato, Mr. Roboto.

The Annals of thoracic surgery·2026
Same author

Flexible outlier detection in multicenter clinical trials.

Journal of clinical and translational science·2026
Same author

BRIDGE: benchmarking large language models for understanding real-world clinical practice texts.

Nature biomedical engineering·2026
Same author

Using large language models to enhance clinically-driven missing data recovery algorithms in electronic health records.

JAMIA open·2026
Same author

Arterial Switch Operation in the First 2 Days of Life.

The Annals of thoracic surgery·2026
Same author

Micro-randomization trial design under operational constraints.

Contemporary clinical trials·2026
Same journal

Power and Sample Size for Longitudinal Models in R - The longpower Package and Shiny App.

The R journal·2026
Same journal

Structured Bayesian Regression Tree Models for Estimating Distributed Lag Effects: The R Package dlmtree.

The R journal·2025
Same journal

CIMTx: An R Package for Causal Inference with Multiple Treatments using Observational Data.

The R journal·2024
Same journal

glmmPen: High Dimensional Penalized Generalized Linear Mixed Models.

The R journal·2024
Same journal

binGroup2: Statistical Tools for Infection Identification via Group Testing.

The R journal·2024
Same journal

The openVA Toolkit for Verbal Autopsies.

The R journal·2023
See all related articles

Related Experiment Video

Updated: Sep 5, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

stratamatch: Prognostic Score Stratification Using a Pilot Design.

Rachael C Aikens1, Joseph Rigdon2, Justin Lee1

  • 1Stanford University.

The R Journal
|July 13, 2022
PubMed
Summary
This summary is machine-generated.

The stratamatch package improves observational studies by creating strata based on prognostic scores. This enhances treatment effect estimation and reduces bias, similar to block-randomized trials.

Keywords:
Rcausal inferencematchingpilot designsprognostic scorestratification

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

365
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

Related Experiment Videos

Last Updated: Sep 5, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

365
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Health Services Research

Background:

  • Block-randomized trials subdivide participants by baseline characteristics to reduce heterogeneity and improve treatment effect estimation.
  • Observational studies often struggle with confounding factors, leading to less precise treatment effect estimates.
  • Existing methods for observational studies may not fully capture the benefits of stratification seen in randomized trials.

Purpose of the Study:

  • To introduce the stratamatch package, which extends block-randomized trial principles to observational studies.
  • To provide functions for data stratification and assessment of stratification schemes in observational data.
  • To enable propensity score matching within strata for more robust treatment effect estimation.

Main Methods:

  • The stratamatch package implements a "pilot design" approach using prognostic scores to stratify observational data.
  • It estimates prognostic scores (Hansen 2008) to divide individuals into strata, informing the matching process.
  • Propensity score matching is then performed within these strata to emulate block-randomized trial designs.

Main Results:

  • Stratification enhances computational efficiency for matching in large observational datasets.
  • Using prognostic scores for stratification increases the precision of treatment effect estimates.
  • This approach reduces sensitivity to bias from unmeasured confounding factors.

Conclusions:

  • The stratamatch approach offers a robust design strategy for observational studies, improving the reliability of findings.
  • Clever use of data in the design phase, via stratification, yields significant benefits in study robustness.
  • This methodology allows observational studies to better approximate the rigorous design of block-randomized controlled trials.